INTS2 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 4.43067804667407E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.93569999713029E-08 |
Normal-vs-Stage2 |
1.584570E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.992220E-02 |
Stage1-vs-Stage2 |
4.805200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
7.929000E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
5.685400E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.51090045924707E-10 |
Normal-vs-AfricanAmerican |
1.64589997186937E-09 |
Normal-vs-Asian |
2.729900E-02 |
Caucasian-vs-AfricanAmerican |
1.981870E-02 |
Caucasian-vs-Asian |
2.812800E-01 |
AfricanAmerican-vs-Asian |
1.140590E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.98516999999621E-05 |
Normal-vs-Female |
1.14799999950677E-07 |
Male-vs-Female |
9.719200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
5.380800E-03 |
Normal-vs-Extreme_Weight |
6.01929999954898E-07 |
Normal-vs-Obese |
1.064640E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
4.933600E-01 |
Normal_Weight-vs-Obese |
7.900100E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
7.802200E-02 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.689760E-01 |
Normal-vs-Age(41-60Yrs) |
1.044590E-04 |
Normal-vs-Age(61-80Yrs) |
7.43480000009455E-07 |
Normal-vs-Age(81-100Yrs) |
2.735200E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.479400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.963400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.688600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.070200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.823200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.758200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
6.315000E-01 |
Normal-vs-Grade 3 |
7.221400E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
2.270200E-01 |
Grade 2-vs-Grade 4 |
6.315000E-01 |
Grade 3-vs-Grade 4 |
7.221400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.87560033749446E-10 |
Normal-vs-N1 |
2.429700E-02 |
N0-vs-N1 |
7.885800E-02 |
|
|